Hudson Bay Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,000
| Closed | -$454K | – | 679 |
|
|
2023
Q3 | $454K | Sell |
10,000
-20,000
| -67% | -$908K | ﹤0.01% | 520 |
|
|
2023
Q2 | $1.68M | Sell |
30,000
-30,000
| -50% | -$1.68M | 0.01% | 464 |
|
|
2023
Q1 | $2.71M | Sell |
60,000
-21,600
| -26% | -$977K | 0.02% | 421 |
|
|
2022
Q4 | $3.32M | Buy |
81,600
+66,600
| +444% | +$2.71M | 0.03% | 450 |
|
|
2022
Q3 | $980K | Hold |
15,000
| – | – | 0.01% | 819 |
|
|
2022
Q2 | $912K | Sell |
15,000
-20,000
| -57% | -$1.22M | 0.01% | 904 |
|
|
2022
Q1 | $2.2M | Buy |
35,000
+11,300
| +48% | +$709K | 0.03% | 657 |
|
|
2021
Q4 | $1.8M | Buy |
23,700
+6,200
| +35% | +$470K | 0.02% | 694 |
|
|
2021
Q3 | $1.96M | Buy |
17,500
+10,000
| +133% | +$1.12M | 0.03% | 608 |
|
|
2021
Q2 | $1.21M | Sell |
7,500
-7,500
| -50% | -$1.21M | 0.01% | 684 |
|
|
2021
Q1 | $1.83M | Buy |
+15,000
| New | +$1.83M | 0.02% | 573 |
|